PAUL B. SAVAGE,CARL A. GENBERG,MICHAEL D. TRIPLETT
申请号：
US14515858
公开号：
US20150110767A1
申请日:
2014.10.16
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Methods of treating, reducing, or preventing lung infections or lung inflammation include identifying a patient in need of treatment and administering a therapeutically effective amount of at least one cationic steroid antimicrobial (CSA), or a pharmaceutically acceptable salt thereof. Treatment of cystic fibrosis lung infections, COPD lung infections, inflammation of the lungs in these patient populations, and lung scarring in these patient populations is also described.
